Trimethylamine-N-oxide may be involved in the pathogenesis of IBD by impacting ATG16L1-induced autophagy and activating NLRP3 inflammasome (Yue et al., 2017; Li et al., 2022). The gene discussed is NLRP3; the disease is inflammatory bowel disease.